Insider Stock Trading History of Flynn Karen


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Flynn Karen since year 2005. The trader's CIK number is 1553599. At the time of this reporting, Flynn Karen is the Director of Recro Pharma, Inc. . (stock ticker symbol REPH). See this page for all insider trading activities at Recro Pharma, Inc. .

Note that in the past Flynn Karen also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Flynn Karen since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-12-16 REPH Recro Pharma, Inc. Buy 800 6.71 5,364
2016-09-06 WST West Pharmaceutical Services Inc Sale 14,581 83.28 1,214,305
2015-11-10 WST West Pharmaceutical Services Inc Option Ex 18,020 20.88 376,311
2015-11-10 WST West Pharmaceutical Services Inc Sale 18,020 63.03 1,135,728
2015-05-22 WST West Pharmaceutical Services Inc Option Ex 3,091 16.05 49,595
2015-05-22 WST West Pharmaceutical Services Inc Sale 3,091 55.24 170,737
2015-05-18 WST West Pharmaceutical Services Inc Option Ex 1,909 16.05 30,629
2015-05-18 WST West Pharmaceutical Services Inc Sale 1,909 55.00 104,995
2013-11-19 WST West Pharmaceutical Services Inc Sale 5,500 47.75 262,625
2013-11-19 WST West Pharmaceutical Services Inc Option Ex 5,500 22.89 125,895

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Flynn Karen (Director of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.